Bayer AG

Bayer AG is a global life science company committed to accelerating pharmaceutical innovation and production through its advanced contract manufacturing and CDMO capabilities. With a legacy spanning more than 160 years, Bayer combines deep scientific expertise, state-of-the-art production technologies, and regulatory excellence to serve partners across the pharmaceutical value chain. At CPHI Frankfurt 2025, Bayer will showcase its full spectrum of contract manufacturing services in Meeting Room G187, Hall 9.1 — highlighting capabilities ranging from API synthesis via classical chemical methods and biocatalysis, to the development and manufacture of biologics, solid dose and lyophilized products, as well as emerging modalities like cell and gene therapies. Whether for small batch launches or large-scale volume production, Bayer delivers through its resilient global network of facilities. Powered by digital transformation, AI-enabled quality control, and best-in-class manufacturing standards (cGMP), Bayer ensures that all processes—from concept and CMC development through commercialization—are efficient, sustainable, and compliant. Their expertise in life cycle support means that partners benefit not only at launch but throughout the product’s journey. Bayer AG continues to be a trusted partner for pharmaceutical companies seeking innovation, reliability, and forward-looking manufacturing solutions in a rapidly evolving industry.